fluorobenzenes has been researched along with Cardiomegaly in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calise, D; Cognet, T; Guilbeau-Frugier, C; Lairez, O; Mialet-Perez, J; Parini, A; Schaak, S | 1 |
| Liang, J; Xu, X; Zhang, L | 1 |
| Bianchi, P; Calise, D; Escourrou, G; Galinier, M; Guilbeau-Frugier, C; Lairez, O; Mialet-Perez, J; Ordener, C; Parini, A; Pizzinat, N; Roncalli, J; Seif, I; Spreux-Varoquaux, O | 1 |
| Kang, BY; Mehta, JL; Palade, P; Sharma, SG; Wang, W | 1 |
| Cha, MJ; Chang, W; Choi, E; Choi, EY; Chung, N; Hwang, KC; Jang, Y; Kim, HJ; Lim, S; Song, BW | 1 |
| Bleske, BE; Boluyt, MO; Cirrincione, GM; Hwang, HS | 1 |
| Böhm, M; Custodis, F; Eberl, M; Kilter, H; Laufs, U | 1 |
| Cooper, SA; Ferrario, C; Habibi, J; Hayden, MR; Muniyappa, R; Qazi, MA; Sowers, JR; Stump, C; Thyfault, J; Tramontano, A; Whaley-Connell, A | 1 |
8 other study(ies) available for fluorobenzenes and Cardiomegaly
| Article | Year |
|---|---|
Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.
Topics: Age Factors; Analysis of Variance; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Fluorobenzenes; Gene Expression Regulation; Hemodynamics; Histone Deacetylases; Male; Mice; Mice, Inbred C57BL; Myocardium; Piperidines; Receptor, Serotonin, 5-HT2A; RNA, Messenger; Serotonin Antagonists | 2013 |
Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Electrocardiography; Fluorobenzenes; GATA4 Transcription Factor; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rosuvastatin Calcium; Signal Transduction; Sulfonamides | 2013 |
Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.
Topics: Animals; Aorta; Blood Pressure; Cardiomegaly; Fibrosis; Fluorobenzenes; Gene Deletion; Gene Expression Regulation; Heart Ventricles; Ketanserin; Mice; Mice, Knockout; Monoamine Oxidase; Myocardium; Piperidines; Pressure; Receptors, Serotonin; Serotonin; Stress, Physiological; Ultrasonography | 2009 |
Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
Topics: Amlodipine; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Cardiomegaly; Cholesterol, Dietary; Disease Models, Animal; Drug Therapy, Combination; Fluorobenzenes; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Mice; Mice, Knockout; Pyrimidines; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2009 |
Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
Topics: Animals; Base Sequence; Calcium; Cardiac Myosins; Cardiomegaly; Cell Membrane; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Fluorobenzenes; GTP-Binding Proteins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Space; Myocytes, Cardiac; Myosin Light Chains; Norepinephrine; Protein Transport; Proto-Oncogenes; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Rosuvastatin Calcium; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sulfonamides; Transfection | 2010 |
3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Body Weight; Cardiomegaly; Collagen; Constriction, Pathologic; DNA Probes; Extracellular Matrix; Fibronectins; Fluorobenzenes; Gene Expression; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cells, Cultured; Fluorobenzenes; Free Radicals; Guanine Nucleotide Dissociation Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoprecipitation; Leucine; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Myocardium; NADPH Oxidases; Protein Binding; Pyrimidines; rac1 GTP-Binding Protein; rho Guanine Nucleotide Dissociation Inhibitor alpha; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA Interference; Rosuvastatin Calcium; Sulfonamides; Superoxides | 2006 |
Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Female; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Glycoproteins; Mice; Myocardium; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Pyrimidines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Renin; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2007 |